A California jury has awarded $8.3 million to a man who received a faulty DePuy ASR hip replacement. Loren Kransky was awarded the sum after the jury found healthcare giant Johnson & Johnson negligent when its subsidiary DePuy released the faulty hip replacement.

According to the Los Angeles Times, healthcare giant Johnson & Johnson played “Russian roulette” with patient safety by ignoring high failure rates and surgeons’ complaints about its once-popular artificial hip, a Los Angeles jury was told during closing arguments at a high-stakes medical trial for the company.

DePuy’s complaint and vigilance manager has testified in the first DePuy hip lawsuit to go to trial that many patient complaints never formally got to his department. Paul Arnott testified that DePuy salesmen were instructing surgeons to send patients with complaints to another surgeon and not file a complaint with DePuy.

Johnson & Johnson’s DePuy unit has issued another hip replacement recall in the wake of high failure rates. The company recalled all 7,5000 units of the DePuy Adept metal-on-metal hip replacement sold around the world after patients required revision surgery to repair the faulty devices.

Greek prosecutors have charged five DePuy officials of bribing hospitals to buy their medical devices. DePuy, a subsidiary of Johnson & Johnson, is currently on trial for its DePuy ASR hip replacement device, which thousands of patients allege caused injuries.

Ann McCracken’s DePuy lawsuit against Johnson & Johnson has been selected as one of two bellwether cases that may determine additional hip replacement lawsuits against the company. More than 7,000 patients have filed DePuy hip implant lawsuits against parent company Johnson & Johnson, alleging that the devices failed and led to injury.